Google "Minutes of the 10 - 11 July 2012 meeting"
Committee for Orphan Medicinal Products (COMP)
Minutes of the 10 - 11 July 2012 meeting held in Uppsala, Sweden
"The Committee has recommended that Dacogen, (Decitabine, EU/3/06/370) for
treatment of acute myeloid leukaemia is not removed from the Community Register of Orphan
Sentiment: Strong Buy
Problem is the approval usually comes 67 days after recommendation which was Monday.
What do you think of the stock price action today?